510(k) Report

FDA applicant

Trividia Health, Inc.

Fort Lauderdale, FL3 decisions2016–20261 recall

FDA records 3 decisions for Trividia Health, Inc. (Fort Lauderdale, FL) from 2016 to 2026: 3 510(k) clearances. Most are in product codes NBW (System, Test, Blood Glucose, Over The Counter) and QRL (Multiple Use Blood Lancet For Single Patient…). Since 2016 its 510(k)s took a median of 189 days from receipt to decision, against 190 for FDA’s reviews in the same codes and years. Its devices cite 2 predicates, 0 of them its own earlier devices. 1 recall is linked to its devices, 1 Class I.

FDA’s records also spell it “Trividia Health”.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical chemistry panel, where it files most

How often FDA has decided Trividia Health, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2022

2016: 12022: 12026 (partial year): 1
2016high 1 (2016) · low 0 (2017)2026

2026 so far, outlined.

Recalls per year

1in 2026

2026 (partial year): 1, 1 Class I
2016high 1 (2026) · low 0 (2016)2026

Class I Class II/III not classified

FIG. 1 — Trividia Health, Inc. by year, 2016–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Trividia Health, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report